Compounds > halofuginone
Page last updated: 2024-08-24

halofuginone and Uterine Neoplasms

halofuginone has been researched along with Uterine Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Lin, J; Wu, X1
Adur, M; Druschitz, SA; Koohestani, F; Kurita, T; MacNeill, AL; Nowak, RA; Qiang, W; Serna, VA1
Arredondo, M; Belton, RJ; Grudzien, MM; Low, PS; Manning, PC; Nowak, RA1
Bahr, JM; Braundmeier, AG; Hales, DB; Machado, SA; Nowak, RA; Quade, BJ1
Al-Hendy, A; Copland, JA; Young, SL1
Nowak, RA1

Reviews

1 review(s) available for halofuginone and Uterine Neoplasms

ArticleYear
Potential nonhormonal therapeutics for medical treatment of leiomyomas.
    Seminars in reproductive medicine, 2004, Volume: 22, Issue:2

    Topics: Bexarotene; Female; Heparin; Humans; Interferon-alpha; Leiomyoma; ortho-Aminobenzoates; Piperidines; Pyridones; Quinazolines; Quinazolinones; Reproduction; Tetrahydronaphthalenes; Thiazolidinediones; Tocopherols; Uterine Neoplasms

2004

Other Studies

5 other study(ies) available for halofuginone and Uterine Neoplasms

ArticleYear
Halofuginone inhibits cell proliferation and AKT/mTORC1 signaling in uterine leiomyoma cells.
    Growth factors (Chur, Switzerland), 2022, Volume: 40, Issue:5-6

    Topics: Animals; Apoptosis; Cell Proliferation; Female; Humans; Leiomyoma; Mechanistic Target of Rapamycin Complex 1; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Uterine Neoplasms

2022
Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.
    Human reproduction (Oxford, England), 2016, Volume: 31, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Body Weight; Cell Proliferation; Female; Humans; Immunohistochemistry; Leiomyoma; Mice, Inbred NOD; Mice, SCID; Piperidines; Quinazolinones; Uterine Neoplasms; Xenograft Model Antitumor Assays

2016
The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells.
    Fertility and sterility, 2010, Mar-01, Volume: 93, Issue:4

    Topics: Apoptosis; Cell Proliferation; Collagen Type I; Collagen Type III; Female; Fibrosis; Growth Inhibitors; Humans; Leiomyoma; Myocytes, Smooth Muscle; Myometrium; Piperidines; Quinazolinones; Transforming Growth Factor beta; Tumor Cells, Cultured; Uterine Neoplasms

2010
Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.
    Biology of reproduction, 2012, Volume: 87, Issue:4

    Topics: Aging; Animals; Antineoplastic Agents; Chickens; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Leiomyoma; Oviducts; Piperidines; Poultry Diseases; Prevalence; Primary Cell Culture; Quinazolinones; Tumor Cells, Cultured; Uterine Neoplasms

2012
Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors.
    Environmental health perspectives, 2000, Volume: 108 Suppl 5

    Topics: Antineoplastic Agents; Blotting, Western; Chromatography, Liquid; Female; Growth Inhibitors; Growth Substances; Humans; Hysterectomy; Hysteroscopy; Immunohistochemistry; Interferon-alpha; Leiomyoma; Phenoxyacetates; Piperidines; Polymers; Protein Synthesis Inhibitors; Pyridones; Quinazolines; Quinazolinones; Receptors, Growth Factor; Uterine Neoplasms

2000